Should I See a Cardiologist for High Cholesterol?

Most people with high cholesterol do not need to see a cardiologist. A primary care doctor can diagnose elevated cholesterol, prescribe statins or other medications, and monitor your progress just fine. But there are situations where a cardiologist or lipid specialist genuinely changes the quality of care you receive, and knowing when you fall into that category can make a real difference in your long-term heart health.

Why Primary Care Handles Most Cholesterol Problems

High cholesterol is one of the most common conditions managed in a primary care office. Your doctor measures your lipid panel, calculates your cardiovascular risk, and decides whether lifestyle changes alone are enough or whether medication is warranted. Current guidelines support this approach. Primary care providers routinely initiate statin therapy, the most widely prescribed cholesterol-lowering drug class, and adjust doses over time. A retrospective study of primary care records found that most high-risk patients were started on moderate-intensity statin therapy consistent with guidelines, though roughly a third stopped taking statins within a year regardless of the dosing pattern.¹

The system does have gaps. Among patients who met criteria for statin therapy in one large analysis, only about one in five actually received a prescription at follow-up.² That under-prescribing is a known issue, and it has more to do with the complexity of shared decision-making, time constraints, and patient hesitation than with physician incompetence. Still, it means that if your primary care doctor has discussed statins with you and you are taking them, you are already receiving the standard of care. A cardiologist visit would not change your treatment plan in most straightforward cases.

Situations Where a Cardiologist Actually Helps

A cardiologist referral is not about prestige or getting “better” care. It is about accessing specific expertise, advanced testing, or newer medications that fall outside the typical primary care toolkit. The clearest triggers fall into a few categories:

• Familial hypercholesterolemia: You have very high LDL from a young age, often with a family history of early heart attacks.
• Existing heart disease: You have already had a heart attack, stroke, stent placement, or bypass surgery.
• Statin intolerance: You have tried multiple statins and cannot tolerate any of them at adequate doses.
• Uncertain risk: Your 10-year cardiovascular risk falls in a gray zone, and your doctor is unsure whether to start medication.
• Persistently elevated LDL: Despite maximum-tolerated statin therapy, your cholesterol remains stubbornly high.

If none of those apply to you, your primary care doctor is the right person to manage your cholesterol. If one or more does, read on.

Familial Hypercholesterolemia

Familial hypercholesterolemia is the single strongest reason to see a specialist for cholesterol. This inherited condition causes LDL levels that are dramatically elevated from birth, often well above 190 mg/dL and sometimes over 300. People with this condition face a high lifetime risk of heart attack, and many develop coronary artery disease decades earlier than expected. Clinical criteria can be used to make the diagnosis, but genetic testing confirms it and is valuable for screening family members.³

Patients with familial hypercholesterolemia typically need aggressive treatment with high-intensity statins plus additional drugs like ezetimibe, and the LDL target is a reduction of at least 50 percent.³ Many also need the newer injectable medications discussed later in this article. A cardiologist or lipid specialist has the experience to coordinate this kind of multi-drug regimen and monitor for complications. Primary care doctors can certainly participate, but the complexity of these cases benefits from specialist oversight.

The condition is underdiagnosed. If your LDL has always been very high, if close relatives had heart attacks before age 55 (men) or 65 (women), or if you notice yellowish deposits near your tendons or eyelids, bring it up with your doctor. Getting a proper diagnosis early can genuinely change your prognosis.

After a Heart Attack or Other Cardiovascular Event

If you have already had a heart attack, stroke, or procedure like a stent or bypass, cholesterol management becomes part of a broader effort called secondary prevention. In this context, a cardiologist is almost always involved, and the evidence strongly supports aggressive lipid-lowering in these patients. An American Heart Association statement emphasized that all physicians caring for high-risk patients should take responsibility for cholesterol management, including cardiovascular specialists, and that intensive cholesterol reduction initiated immediately has the potential to reduce both illness and death.⁴

Hospital-based programs that start these medications before discharge have shown clear improvements. One such program dramatically increased statin use from 6 percent to 86 percent at hospital discharge and saw a significant increase in patients reaching their LDL target, along with reduced rates of recurrent heart attack and death within a year.⁵ The lesson here is that after a cardiac event, your cardiologist is not just managing your cholesterol in isolation. They are coordinating it alongside blood pressure medications, antiplatelet drugs, and other therapies as part of an integrated strategy.

When Statins Give You Trouble

Muscle aches are the most common reason people stop taking statins. If you have tried one statin and experienced soreness, that does not mean all statins are off the table, and it does not necessarily mean you need a specialist. Your primary care doctor can try a different statin, lower the dose, or adjust how often you take it. These steps work for the vast majority. Research shows that more than 90 percent of patients reporting statin-associated muscle symptoms can stay on statin therapy long-term after switching to a different statin or adjusting the dose or frequency.⁶

Where a specialist becomes valuable is in the subset of patients who have tried multiple statins at various doses and still cannot tolerate them, especially when their cardiovascular risk is high enough that going without cholesterol-lowering medication is dangerous. A European expert panel recommended that when patients cannot tolerate standard dosing, alternate-day or twice-weekly dosing with long-acting statins can reduce LDL by roughly 12 to 38 percent and is tolerated by about 70 percent of previously intolerant patients.⁷ If even these workarounds fail, a cardiologist or lipid specialist can prescribe non-statin alternatives, including PCSK9 inhibitors, that are typically initiated by specialists rather than primary care providers.⁸

Advanced Testing You Might Not Get From Primary Care

Standard cholesterol panels measure total cholesterol, LDL, HDL, and triglycerides. For most people, that is enough. But when your risk picture is muddled or your numbers do not quite add up, a cardiologist may order tests that primary care offices rarely use.

Coronary Artery Calcium Scoring

A coronary artery calcium (CAC) scan is a quick, low-radiation CT scan that detects calcium deposits in the walls of your heart’s arteries. A score of zero means no detectable calcium and a very low near-term risk of heart attack, even if your cholesterol is elevated. A high score means plaque is already building up, which can tip a borderline treatment decision firmly toward starting medication. Guidelines state that CAC scoring is reasonable for adults aged 40 to 75 whose risk falls in an intermediate zone and for whom the decision to start a statin remains uncertain.⁹ Data from the Multi-Ethnic Study of Atherosclerosis supports CAC scoring as a useful tool to more accurately classify people at intermediate risk who might benefit from statin therapy.¹⁰

A cost-effectiveness analysis found that targeting statin treatment to those with a CAC score above zero could provide about 45 percent of the benefit of treating everyone, while avoiding medication for those unlikely to benefit.¹¹ If you are on the fence about starting a statin and your doctor has not discussed a CAC scan, a cardiologist referral could be worthwhile specifically for this test. Some primary care doctors do order CAC scans, but in many health systems it requires a cardiology referral or at least consultation.

Apolipoprotein B and Lipoprotein(a)

Beyond the standard lipid panel, two additional blood markers can sharpen your risk picture. Apolipoprotein B (apoB) measures the total number of cholesterol-carrying particles in your blood that can burrow into artery walls, providing a more direct count of the particles that actually drive plaque buildup. Lipoprotein(a), often written as Lp(a), is a genetically determined particle that raises cardiovascular risk independently of LDL and does not respond to statins or lifestyle changes.¹² A high Lp(a) level is something you are born with, and knowing about it changes how aggressively a clinician might treat your other risk factors. These tests are becoming more common but are still more likely to be ordered by a specialist than a primary care physician.

Newer Cholesterol Medications That Specialists Prescribe

If your LDL remains too high despite statins and ezetimibe, or if you truly cannot take statins, a class of drugs called PCSK9 inhibitors can produce dramatic reductions in LDL. These medications work by blocking a protein that normally degrades LDL receptors on liver cells, letting the liver pull more cholesterol out of your blood. The original PCSK9 inhibitors (evolocumab and alirocumab) are injectable antibodies given every two to four weeks. They lower LDL substantially and have been shown to reduce cardiovascular events in large trials.

A newer option, inclisiran, uses a different approach. Rather than blocking the PCSK9 protein after it is made, inclisiran silences the gene that produces it, achieving comparable LDL reductions with just two injections per year after an initial loading dose.¹³ A network meta-analysis found that inclisiran produced significantly greater LDL reduction compared to statins alone and ranked highest among the compared treatments for LDL lowering.¹⁴ The long-term cardiovascular outcome data for inclisiran is still being gathered, but its dosing convenience is a major advantage for patients who struggle with adherence.¹⁵

These medications are expensive and often require prior authorization from insurance. In practice, a cardiologist or lipid specialist is almost always the one prescribing them, partly because insurers demand documentation of failed prior therapies and partly because primary care doctors may be less familiar with the prescribing process. If you are a candidate for these drugs, a specialist referral is essentially unavoidable.

The Role of Shared Decision-Making

One scenario that sometimes leads people to seek a cardiology opinion is genuine uncertainty about whether to start medication. If your calculated 10-year risk is borderline or intermediate, the decision is not automatic. Guidelines emphasize a clinician-patient risk discussion that weighs the potential benefit of a statin against the possibility of side effects, drug interactions, and your own values and preferences.¹⁶ If that conversation leaves things unresolved, the American Heart Association and American College of Cardiology suggest that additional testing like a CAC scan or consideration of risk-enhancing factors such as family history can help clarify the decision.¹⁷

A cardiologist visit can serve this purpose: not because your primary care doctor made an error, but because a second opinion from someone who spends all day thinking about cardiovascular risk can settle a close call. This is especially useful if you have risk-enhancing factors that standard calculators may not fully capture, like a strong family history, South Asian ancestry, chronic inflammatory conditions, or an elevated Lp(a).

Preventive Cardiology as a Growing Specialty

Some academic medical centers now have preventive cardiology clinics that focus specifically on cholesterol, lifestyle modification, and long-term risk reduction rather than on procedures like catheterizations or surgeries. A pilot analysis of one such clinic found that patients enrolled in a preventive cardiology program lost more weight and achieved greater reductions in LDL, total cholesterol, and triglycerides compared to patients managed in other clinic settings.¹⁸ The LDL reduction in the preventive clinic group was about 25 mg/dL greater than in the comparison group over a similar period.

These clinics combine medication management with dietary counseling and exercise programming in a way that many busy primary care practices cannot. If your cholesterol is part of a broader metabolic picture that includes weight management, blood sugar concerns, and inflammatory markers, a preventive cardiology clinic can address the whole package. They are not yet available everywhere, but they represent a middle ground between a standard cardiologist visit and a routine primary care check-up.

Do Not Overlook Non-Cardiac Causes

Before assuming your cholesterol problem requires a heart specialist, it is worth making sure a treatable underlying condition is not driving the numbers up. Thyroid dysfunction is a classic culprit. An underactive thyroid raises LDL and total cholesterol, and treating the thyroid problem can improve or even normalize your lipid levels without additional cholesterol medication. A review of the evidence concluded that thyroid dysfunction should always be considered when evaluating and treating patients with abnormal lipid levels.¹⁹ Other secondary causes include kidney disease, certain liver conditions, and some medications like corticosteroids or certain blood pressure drugs. Your primary care doctor should check for these before escalating your care to a specialist.

Who Gets Referred and Who Does Not

Access to specialist care is not evenly distributed, and the disparities are worth knowing about. Consistent gaps exist across racial, ethnic, gender, and socioeconomic lines in access to specialist care and in prescription of guideline-based cholesterol therapies.²⁰ Gender disparities are particularly well documented. A large retrospective study found that women with atherosclerotic cardiovascular disease were about 15 to 18 percent less likely to visit a cardiologist than men, and those who did see a cardiologist were substantially less likely to receive a statin or ezetimibe prescription from that specialist.²¹

These numbers suggest that if you are a woman, a member of a racial or ethnic minority group, or someone with fewer financial resources, you may need to be more proactive about requesting a specialist referral when the clinical situation warrants it. The medical system does not always offer it equally. Knowing the specific scenarios that justify a referral, the ones described throughout this article, puts you in a better position to advocate for yourself.